研究者
J-GLOBAL ID：202401014215500418
更新日: 2025年03月14日 東 公一
アズマ コウイチ | AZUMA KOICHI
久留米大学 医学部医学科 内科学講座(呼吸器・神経・膠原病部門)
久留米大学 医学部医学科 内科学講座(呼吸器・神経・膠原病部門) について
職名： 准教授
論文 (126件)：
- Yoshihito Kogure, Hiroya Hashimoto, Haruko Daga, Yasushi Fukuda, Akihiro Bessho, Tadaaki Yamada, Yukihiro Toi, Tomoki Kimura, Hiroshige Yoshioka, Koichi Azuma, et al. Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50. JTO clinical and research reports. 2025. 6. 3. 100784-100784
- Daiki Murata, Koichi Azuma, Yuuya Nishii, Kenta Murotani, Goushi Matama, Akihiko Kawahara, Takaaki Tokito, Tetsuro Sasada, Tomoaki Hoshino. The Impacts of Active and Inactive Ghrelin on Cachexia and Immune Checkpoint Inhibitor Monotherapy in Patients with Non-Small Cell Lung Cancer. Chemotherapy. 2025. 1-7
- Hiroaki Akamatsu, Shinya Sakata, Koichi Azuma, Hiroshige Yoshioka, Takehiro Uemura, Yuko Tsuchiya-Kawano, Seiya Esumi, Takashi Kurosaki, Yuki Sato, Tomohiro Sakamoto, et al. A single-arm, phase II study of sotorasib plus carboplatin/pemetrexed in advanced non-squamous non-small cell lung cancer patients with KRAS G12C mutation (WJOG14821L, SCARLET). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2025
- Tomoya Fukui, Nobuaki Mamesaya, Toshiaki Takahashi, Kazuma Kishi, Takahiro Yoshizawa, Takaaki Tokito, Koichi Azuma, Kei Morikawa, Satoshi Igawa, Yusuke Okuma, et al. A Prospective Phase II Trial of First-Line Osimertinib for Patients With EGFR Mutation-Positive NSCLC and Poor Performance Status (OPEN/TORG2040). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2025
- Yosuke Kakiuchi, Koichi Saruwatari, Kenta Murotani, Takaaki Tokito, Toyohisa Iriki, Jun Iwakawa, Yoshihiko Sakata, Naoki Shingu, Sho Saeki, Megumi Inaba, et al. Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study. Clinical lung cancer. 2024. 25. 8. 661-671
- Takeharu Ono, Koichi Azuma, Akihiko Kawahara, Tetsuro Sasada, Satoshi Hattori, Fumihiko Sato, Shun-Ich Chitose, Buichiro Shin, Jun Akiba, Hirohito Umeno. Relevance between PD-L1 expression combined with tumor infiltrating lymphocytes and prognosis in advanced hypopharyngeal squamous cell carcinoma. JOURNAL OF CLINICAL ONCOLOGY. 2017. 35
- Hayato Kaida, Koichi Azuma, Akihiko Kawahara, Eiji Sadashima, Satoshi Hattori, Jun Akiba, Axel Rominger, Shinzo Takamori, Kiminori Fujimoto, Makoto Hosono, et al. Prognostic impact of F-18-FDG PET parameters and molecular markers expression in resected non-small cell lung cancer patients. JOURNAL OF NUCLEAR MEDICINE. 2017. 58
- Yuichi Takiguchi, Toyoaki Hida, Hiroshi Nokihara, Masashi Kondo, Young Hak Kim, Koichi Azuma, Takashi Seto, Makoto Nishio, Hiroshige Yoshioka, Fumio Imamura, et al. Updated efficacy and safety of the j-alex study comparing alectinib (ALC) with crizotinib (CRZ) in ALK-inhibitor naive ALK fusion positive non-small cell lung cancer (ALK plus NSCLC). JOURNAL OF CLINICAL ONCOLOGY. 2017. 35
- Norikazu Matsuo, Koichi Azuma, Kazuko Sakai, Akihiko Kawahara, Hidenobu Ishii, Takaaki Tokito, Takashi Kinoshita, Kazuhiko Yamada, Kazuto Nishio, Tomoaki Hoshino. Association of EGFR Exon 19 Deletion and EGFR-TKI treatment duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 1. S1201-S1202
- Toshio Shimizu, Hiroshi Nokihara, Haruyasu Murakami, Takashi Seto, Makoto Nishio, Koji Takeda, Akira Inoue, Katsuyuki Kiura, Koichi Azuma, Anne Keating, et al. Phase I/II study of ASP8273 in patients with non-small-cell lung cancer (NSCLC) harboring EGFR activating mutations. ANNALS OF ONCOLOGY. 2015. 26. 82-82
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。
前のページに戻る
